Dr Nathaniel Calloway

Associate director

Nathaniel Calloway joined the healthcare team in December 2015. Previously, he performed healthcare investment research for a fund at Bishop Rosen and for Wainscott Capital Partners. Prior to his role as an analyst he performed molecular neuroscience research at Cornell Medical School and holds a PhD in chemistry from Cornell. He has published eight scientific papers on topics ranging from physical chemistry to immunology, and has been recognised as an American Heart Association fellow and an ACS Medicinal Chemistry fellow.

Email Nathaniel